国家药监局发布《关于深化化妆品监管改革促进产业高质量发展的意见》

Core Viewpoint - The National Medical Products Administration (NMPA) has released a set of reform measures aimed at enhancing the regulation of cosmetics in China, focusing on promoting high-quality development in the industry [1] Group 1: Reform Measures - The reforms consist of 24 measures across five key areas: encouraging innovation, optimizing registration and filing management, strengthening risk prevention across the entire supply chain, enhancing smart regulatory capabilities, and aligning regulations with international standards [1] - The goal is to solidify the quality and safety baseline of cosmetics, cultivate new productive forces, and drive high-quality development in the cosmetics industry [1] Group 2: Future Goals - By 2030, the regulatory legal framework for cosmetics is expected to be more complete, with a more robust standard system, stronger technical support, increased innovation vitality, enhanced risk prevention capabilities, and significantly improved quality and safety levels [1] - By 2035, the cosmetics quality and safety regulatory system aims to reach international advanced levels, with the industry exhibiting greater innovation and global competitiveness, and achieving modernization in regulation [1]